Sequenom’s en banc petition rejected by Federal Circuit
02-12-2015
CAFC must end ‘existential threat’ to patents, argues Sequenom
19-08-2015
Federal Circuit invalidates Sequenom patent, cites Mayo
17-06-2015
baldyrgan / Shutterstock.com
Ariosa Diagnostics has urged the US Court of Appeals for the Federal Circuit to reject Sequenom’s en banc request, stating that behind its “sky is falling” rhetoric is really a demand for courts to revise the US Supreme Court’s two-part test in determining the eligibility of a patent.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
US Court of Appeals for the Federal Circuit; Sequenom; Ariosa; patents; US Supreme Court; Myriad; Mayo; Diehr; BIO
